<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0002921"><a href="http://purl.obolibrary.org/obo/MONDO_0002921">MONDO:0002921</a></h3>
<p><strong>Label:</strong> congenital structural myopathy</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0012240">MONDO:0012240</a> (nemaline myopathy 4), <a href="http://purl.obolibrary.org/obo/MONDO_0011271">MONDO:0011271</a> (rigid spine muscular dystrophy 1), <a href="http://purl.obolibrary.org/obo/MONDO_0015738">MONDO:0015738</a> (childhood-onset nemaline myopathy), <a href="http://purl.obolibrary.org/obo/MONDO_0015737">MONDO:0015737</a> (Typical nemaline myopathy), <a href="http://purl.obolibrary.org/obo/MONDO_0007294">MONDO:0007294</a> (central core myopathy), <a href="http://purl.obolibrary.org/obo/MONDO_0018958">MONDO:0018958</a> (nemaline myopathy), <a href="http://purl.obolibrary.org/obo/MONDO_0018948">MONDO:0018948</a> (multiminicore myopathy), <a href="http://purl.obolibrary.org/obo/MONDO_0015736">MONDO:0015736</a> (intermediate nemaline myopathy), <a href="http://purl.obolibrary.org/obo/MONDO_0008070">MONDO:0008070</a> (nemaline myopathy 3), <a href="http://purl.obolibrary.org/obo/MONDO_0012239">MONDO:0012239</a> (nemaline myopathy 1), <a href="http://purl.obolibrary.org/obo/MONDO_0015735">MONDO:0015735</a> (severe congenital nemaline myopathy),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_171433">Orphanet:171433</a>, <a href="http://purl.obolibrary.org/obo/OMIM_117000">OMIM:117000</a>, <a href="http://www.orpha.net/ORDO/Orphanet_84132">Orphanet:84132</a>, <a href="http://www.orpha.net/ORDO/Orphanet_171430">Orphanet:171430</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178145">Orphanet:178145</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609273">OMIM:609273</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615348">OMIM:615348</a>, <a href="http://www.orpha.net/ORDO/Orphanet_97244">Orphanet:97244</a>, <a href="http://www.orpha.net/ORDO/Orphanet_598">Orphanet:598</a>, <a href="http://purl.obolibrary.org/obo/OMIM_602771">OMIM:602771</a>, <a href="http://www.orpha.net/ORDO/Orphanet_597">Orphanet:597</a>, <a href="http://www.orpha.net/ORDO/Orphanet_324604">Orphanet:324604</a>, <a href="http://www.orpha.net/ORDO/Orphanet_171881">Orphanet:171881</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616165">OMIM:616165</a>, <a href="http://purl.obolibrary.org/obo/OMIM_255320">OMIM:255320</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609284">OMIM:609284</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615731">OMIM:615731</a>, <a href="http://www.orpha.net/ORDO/Orphanet_171439">Orphanet:171439</a>, <a href="http://www.orpha.net/ORDO/Orphanet_607">Orphanet:607</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98904">Orphanet:98904</a>, <a href="http://www.orpha.net/ORDO/Orphanet_171436">Orphanet:171436</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610687">OMIM:610687</a>, <a href="http://purl.obolibrary.org/obo/OMIM_256030">OMIM:256030</a>, <a href="http://purl.obolibrary.org/obo/OMIM_161800">OMIM:161800</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609285">OMIM:609285</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0100303">HP:0100303</a> (Muscle fiber cytoplasmatic inclusion bodies) 68.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003798">HP:0003798</a> (Nemaline bodies) 68.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100303">HP:0100303</a> (Muscle fiber cytoplasmatic inclusion bodies) 68.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003798">HP:0003798</a> (Nemaline bodies) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) 68.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100303">HP:0100303</a> (Muscle fiber cytoplasmatic inclusion bodies) 66.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003798">HP:0003798</a> (Nemaline bodies) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) 66.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001324">HP:0001324</a> (Muscle weakness) and <a href="http://purl.obolibrary.org/obo/HP_0100303">HP:0100303</a> (Muscle fiber cytoplasmatic inclusion bodies) 66.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001324">HP:0001324</a> (Muscle weakness) and <a href="http://purl.obolibrary.org/obo/HP_0003798">HP:0003798</a> (Nemaline bodies) 66.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) and <a href="http://purl.obolibrary.org/obo/HP_0100303">HP:0100303</a> (Muscle fiber cytoplasmatic inclusion bodies) 66.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) and <a href="http://purl.obolibrary.org/obo/HP_0003798">HP:0003798</a> (Nemaline bodies) 66.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100303">HP:0100303</a> (Muscle fiber cytoplasmatic inclusion bodies) 66.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003798">HP:0003798</a> (Nemaline bodies) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) 66.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001324">HP:0001324</a> (Muscle weakness) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100303">HP:0100303</a> (Muscle fiber cytoplasmatic inclusion bodies) 66.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001324">HP:0001324</a> (Muscle weakness) and <a href="http://purl.obolibrary.org/obo/HP_0003798">HP:0003798</a> (Nemaline bodies) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) 66.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100303">HP:0100303</a> (Muscle fiber cytoplasmatic inclusion bodies) 66.00%</li>
</ul>
</body>
</html>
